Cargando…
Immunotherapy in extensive small cell lung cancer
Small cell lung cancer which constitutes about 15% of lung cancers is pathobiologically and clinically distinct from non small cell cancer. Histologically it is characterized by small cells with scant cytoplasm, absent or inconspicuous nucleoli, extensive necrosis, and expresses neuroendocrine marke...
Autores principales: | Verma, Vaibhav, Sharma, Geeti, Singh, Abhijai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360752/ https://www.ncbi.nlm.nih.gov/pubmed/30740266 http://dx.doi.org/10.1186/s40164-019-0129-x |
Ejemplares similares
-
Immunotherapy in Extensive-Stage Small Cell Lung Cancer
por: El Sayed, Rola, et al.
Publicado: (2021) -
Immunotherapy for extensive stage small cell lung cancer
por: Pacheco, Jose M.
Publicado: (2020) -
Lung Cancer Screening for the Poor and Underserved: Should Routine Screening be Performed?
por: Verma, Vaibhav, et al.
Publicado: (2012) -
The role of thoracic consolidative radiotherapy in the setting of immunotherapy in extensive stage small cell lung cancer
por: Verma, Saurav, et al.
Publicado: (2023) -
The Role of Immunotherapy in Extensive Stage Small-Cell Lung Cancer: A Review of the Literature
por: Tsiouprou, Ioanna, et al.
Publicado: (2019)